In the latest trading session, 0.57 million Oncology Institute Inc (NASDAQ:TOI) shares changed hands as the company’s beta touched 0.44. With the company’s most recent per share price at $0.16 changing hands around $0.0 or -3.09% at last look, the market valuation stands at $11.30M. TOI’s current price is a discount, trading about -1462.5% off its 52-week high of $2.50. The share price had its 52-week low at $0.13, which suggests the last value was 18.75% up since then. When we look at Oncology Institute Inc’s average trading volume, we note the 10-day average is 6.39 million shares, with the 3-month average coming to 1.10 million.
Analysts gave the Oncology Institute Inc (TOI) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended TOI as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Oncology Institute Inc’s EPS for the current quarter is expected to be 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Oncology Institute Inc (NASDAQ:TOI) trade information
Instantly TOI was in red as seen in intraday trades today. With action 1.95%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -92.30%, with the 5-day performance at 1.95% in the green. However, in the 30-day time frame, Oncology Institute Inc (NASDAQ:TOI) is -49.35% down. Looking at the short shares, we see there were 0.25 million shares sold at short interest cover period of 3.38 days.
The consensus price target for the stock as assigned by Wall Street analysts is 8, meaning bulls need an upside of 98.0% from its recent market value. According to analyst projections, TOI’s forecast low is 6 with 10 as the target high. To hit the forecast high, the stock’s price needs a -6150.0% plunge from its current level, while the stock would need to soar -3650.0% for it to hit the projected low.
Oncology Institute Inc (NASDAQ:TOI)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 19.56% of Oncology Institute Inc shares while 47.59% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 59.16%. There are 47.59% institutions holding the Oncology Institute Inc stock share, with FMR LLC the top institutional holder. As of 2024-06-30, the company held 6.4005% of the shares, roughly 4.75 million TOI shares worth $2.19 million.
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) holds the second largest percentage of outstanding shares, with 4.5263% or 3.36 million shares worth $1.55 million as of 2024-06-30.
